Cinnamaldehyde

Cinnamaldehyde

SCHEMBL5884331

CCCCNCCCC.O=CC=Cc1ccccc1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.62
ALDH1A1 P00352 2/20 0.62
TRPA1 O75762 1/20 0.62
ALOX5 P09917 1/20 0.62
MAPK1 P28482 1/20 0.62
HDAC3 O15379 2/20 0.51
EGFR P00533 1/20 0.48
SIGMAR1 Q99720 1/20 0.46
TDP1 Q9NUW8 2/20 0.45
MAOB P27338 1/20 0.43
HTT P42858 1/20 0.42
KDM4E B2RXH2 4/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CDK4 P11802 1/20 0.41
CCNB1 P14635 1/20 0.41
CCND1 P24385 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinnamaldehyde SCHEMBL28716525 0.83 ALDH1A1 (0.62) LMNAALDH1A1TRPA1ALOX5MAPK1
Cinnamaldehyde SCHEMBL29210909 0.83 LMNA (0.62) LMNAALDH1A1TRPA1ALOX5MAPK1
Cinnamaldehyde SCHEMBL28716524 0.83 ALDH1A1 (0.62) LMNAALDH1A1TRPA1ALOX5MAPK1
Cinnamaldehyde SCHEMBL28633503 0.82 ALDH1A1 (0.67) LMNAALDH1A1TRPA1ALOX5MAPK1
Cinnamaldehyde SCHEMBL28633504 0.82 ALDH1A1 (0.67) LMNAALDH1A1TRPA1ALOX5MAPK1
Cinnamaldehyde SCHEMBL8420413 0.82 ALDH1A1 (0.72) LMNAALDH1A1TRPA1ALOX5MAPK1
Benzaldehyde SCHEMBL1169911 0.82 ALDH1A1 (0.56) LMNAALDH1A1HDAC3EGFRSIGMAR1
(Z)-1,2-Diphenylethene SCHEMBL5489824 0.82 SIGMAR1 (0.61) LMNAALDH1A1HDAC3EGFRSIGMAR1
Cinnamaldehyde SCHEMBL20912968 0.81 ALDH1A1 (0.60) LMNAALDH1A1TRPA1ALOX5MAPK1
Cinnamaldehyde SCHEMBL20912967 0.81 ALDH1A1 (0.60) LMNAALDH1A1TRPA1ALOX5MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078542-B2 Nonlinear optical compounds and methods for their preparation UNIVERSITY OF WASHINGTON (US) 2006-07-18 US disclosed
US-7014796-B2 Nonlinear optical compounds and methods for their preparation UNIVERSITY OF WASHINGTON (US) 2006-03-21 US disclosed
US-20050023507-A1 pi-electron donor group bonded to a pi-electron conjugated bridge group bonded to a mono- or dicyanodihydrofuran acceptor; large hyperpolarizability, dipole moment, and electrooptic coefficients; electrooptics UNIVERSITY OF WASHINGTON (US) 2005-02-03 US disclosed
WO-2004065384-A1 NONLINEAR OPTICAL COMPOUNDS AND METHODS FOR THEIR PREPARATION UNIVERSITY OF WASHINGTON (US) 2004-08-05 WO disclosed
US-20040135130-A1 Nonlinear optical compounds and methods for their preparation UNIVERSITY OF WASHINGTON 2004-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050023507-A1 pi-electron donor group bonded to a pi-electron conjugated bridge group bonded to a mono- or dicyanodihydrofuran acceptor; large hyperpolarizability, dipole moment, and electrooptic coefficients; electrooptics PCNA, ETFA, POF1B LMNA 1276/4885ALDH1A1 2191/4885TRPA1 2770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.